The store will not work correctly when cookies are disabled.
SODIUM MOLYBDATE
ID: ALA1801596
Max Phase: Preclinical
Molecular Formula: MoNa2O4
Molecular Weight: 205.92
Molecule Type: Small molecule
Associated Items:
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 205.92 | Molecular Weight (Monoisotopic): 207.8646 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
1. Davenport J, Manjarrez JR, Peterson L, Krumm B, Blagg BS, Matts RL.. (2011) Gambogic acid, a natural product inhibitor of Hsp90., 74 (5): [PMID:21486005] [10.1021/np200029q] |